■ Cardiovascular risk in type 1 diabetes mellitus
Jonathan Schofield, Jan Ho, Handrean Soran
Diabetes Ther. 2019 Jun; 10(3): 773–78
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531592/
■ The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
Alicia Jenkins, Andrzej Januszewski, David O’Neal
Cardiovasc Endocrinol Metab. 2019, vol 8(1): 14–27
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739889/
■ Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburg Epidemiology of Diabetes Complications study
Tina Costacou, Trevor J. Orchard
Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 3–13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739893/
■ Type 1 diabetes mellitus and coronary revascularization
Helene Mamet, Mark C. Petrie, Paul Rocchiccioli
Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 35–38
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739890/
■ Vascular disease in the lower limb in type 1 diabetes
Michael Edmonds
Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 39–46
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739894/
■ Psicologia e adolescentes com diabetes mellitus tipo 1: uma revisão sistemática
L C M Ribeiro, R L dos Santos Aléssio, B S Almeida
Adolescencia & Saúde 2018, vol 15 (3)
http://www.adolescenciaesaude.com/detalhe_artigo.asp?id=739
■ Prediction and prevention of type 1 diabetes in children
Francesco Chiarelli, Cosimo Giannini, Marina Primavera
Clin Pediatr Endocrinol. 2019; 28(3): 43–57
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646239/
■ A review of insulin resistance in type 1 diabetes: Is there a place for adjunctive metformin?
Gagan Priya, Sanjay Kalra
Diabetes Ther. 2018 Feb; 9(1): 349–361
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801219/
■ Fast-acting insulin aspart: the rationarle for a new mealtime insulin
Marc Evans, Mathew Wilkinson, Angeliki Giannpolou
Diabetes Ther. 2019 Oct; 10(5): 1793–1800
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778592/
■ A review of the safety and adverse event profile of the fixed-ratio combination of insulin glargine and lixisenatide
Juan P. Frias, Terry Dex, Michelle Roberts, Allen Kaplan
Diabetes Ther. 2019 Feb; 10(1): 21–33
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502244/
■ Partial clinical remission of type 1 diabetes mellitus in children: clinical application and challenges with its definitions
Benjamin Udoka Nwosu
Eur Med J Diabetes. 2019, vol 4(1): 89–98
■ Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of type 1 diabetes mellitus – a narrative review
Karolina Rak, Monika Bronkowska
Molecules. 2019, vol 24(1): 53
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337255/
■ Genetic aspects of type 1 diabetes
Hae Sang Lee, Jin Soon Hwang
Ann Pediatr Endocrinol Metab. 2019, vol 24(3): 143–148
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790877/
■ Is there any association between gut microbiota and type 1 diabetes?
Parnian Jamshidi, Saba Hasanzadeh, Azin Tahvildari et al
Gut Pathog. 2019; vol 11: 49
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791003/
■ Environmental factors associated with type 1 diabetes
Susanna Esposito, Giada Toni, Giorgia Tascini, Elisa Santi, Maria Giulia Berioli, Nicola Principi
Front Endocrinol (Lausanne) 2019; vol 10: 592
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722188/
■ Immune chekpoint inhibitor-induced type 1 diabetes: a systematic review and meta-analysis
- K. Akturk, D. Kahramangil, A. Sarwal et al
Diabet Med. 2019, vol 36(9): 1075–1081
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698212/
■ Type 1 diabetes
Linda A DiMeglio, Carmella Evans-Molina, Richard A Oram
Lancet. 2018 Jun 16; 391(10138): 2449–2462
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661119/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: nov 2019